| Literature DB >> 26168192 |
Pradeep R Dumpala1, Brian C Peterson2, Mark L Lawrence3, Attila Karsi3.
Abstract
Edwardsiella ictaluri is a Gram-negative facultative anaerobe intracellular bacterium that causes enteric septicemia in channel catfish. Iron is an essential inorganic nutrient of bacteria and is crucial for bacterial invasion. Reduced availability of iron by the host may cause significant stress for bacterial pathogens and is considered a signal that leads to significant alteration in virulence gene expression. However, the precise effect of iron-restriction on E. ictaluri protein abundance is unknown. The purpose of this study was to identify differentially abundant proteins of E. ictaluri during in vitro iron-restricted conditions. We applied two-dimensional difference in gel electrophoresis (2D-DIGE) for determining differentially abundant proteins and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI TOF/TOF MS) for protein identification. Gene ontology and pathway-based functional modeling of differentially abundant proteins was also conducted. A total of 50 unique differentially abundant proteins at a minimum of 2-fold (p ≤ 0.05) difference in abundance due to iron-restriction were detected. The numbers of up- and down-regulated proteins were 37 and 13, respectively. We noted several proteins, including EsrB, LamB, MalM, MalE, FdaA, and TonB-dependent heme/hemoglobin receptor family proteins responded to iron restriction in E. ictaluri.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26168192 PMCID: PMC4500449 DOI: 10.1371/journal.pone.0132504
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Fluorescent difference gel electrophoresis (2-D DIGE) of Edwardsiella ictaluri grown in iron-rich and iron-restricted conditions.
Fifty μg of soluble protein from E. ictaluri grown in regular brain heart infusion (BHI) media was labeled with Cy3, grown in BHI with chelator 2, 2’-dipyridyl was labeled with Cy5, and the pooled internal standard labelled with Cy2. Spots shown in red and green arrow head are up- and down-regulated (≥2 fold), respectively. 3D images of 2 spots with maximum and minimum fold up-regulated proteins were shown on left top and bottom corners of gel image, respectively. 3D images of 2 spots with maximum and minimum fold down-regulated proteins were shown on right top and bottom corners of gel image, respectively.
Differentially regulated proteins of Edwardsiella ictaluri in response to in vitro iron-restriction.
| Process/GI number | Protein number | Spot ID | Fold difference | CI% | Protein name | Protein MW/PI | Pep. count | Protein score | Gene name |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| 238919566 | 1 | 194/195 | 3.82/2.68 | 100 | Aldehyde-alcohol dehydrogenase 2 | 95992.7/6.41 | 28 | 413 | NT01EI_1665 |
|
| |||||||||
| 238919324 | 2 | 350/346 | 2.89/2.49 | 100 | Bifunctional polymyxin resistance protein ArnA, putative | 73954/5.67 | 26 | 264 | arnA/NT01EI_1415 |
| 238920260 | 3 | 1972 | -4.14 | 100 | 3-oxoacyl-[acyl-carrier-protein] reductase, putative | 25567.1/5.95 | 9 | 244 | NT01EI_2369 |
|
| |||||||||
| 238921292 | 4 | 1811 | 5.48 | 100 | N-acetylmuramoyl-L-alanine amidase AmiD | 28647.3/6.6 | 11 | 220 | NT01EI_3435 |
| 238920353 | 5 | 182 | 3.63 | 100 | Formate acetyltransferase, putative | 85051.6/5.65 | 22 | 154 | NT01EI_2463 |
| 238921224 | 6 | 1347/1352/1316 | 3.03 | 100 | Fructose-bisphosphate aldolase, putative | 39129.7/5.65 | 14 | 382 | fba or fda/NT01EI_3367 |
| 238918053 | 7 | 1301 | 3.55 | 99.99 | ADP-glyceromanno-heptose 6-epimerase, putative | 34791/5.29 | 9 | 77 | hldD/NT01EI_0072 |
| 238918174 | 8 | 715 | 2.45 | 100 | Glucose-6-phosphate isomerase | 61392.9/6.06 | 19 | 243 | pgi/NT01EI_0210 |
| 238920733 | 9 | 1809 | 3.05 | 100 | Hypothetical protein NT01EI_2846 | 28196.7/6.56 | 18 | 454 | gpmA/NT01EI_2846 |
| 238921491 | 10 | 699/690 | 3.16/3.24 | 100 | Phosphoenolpyruvate carboxykinase (ATP) | 59171.9/5.77 | 28 | 571 | pckA/NT01EI_3643 |
|
| |||||||||
| 238918513 | 11 | 1034 | 2.84 | 100 | Thymidine phosphorylase, putative | 46793.9/5.33 | 14 | 139 | NT01EI_0563 |
| 238918595 | 12 | 1236 | 2.33 | 100 | Hypothetical protein NT01EI_0651 | 38512.4/8.34 | 12 | 209 | NT01EI_0651 |
| 238918515 | 13 | 1888 | 2.17 | 100 | Purine nucleoside phosphorylase, putative | 25636.8/5.4 | 11 | 292 | deoD/NT01EI_0565 |
| 238918109 | 14 | 1801 | 3.33 | 100 | Uridine phosphorylase, putative | 27335.9/6.07 | 13 | 645 | NT01EI_0133 |
| 238918514 | 15 | 1051 | 2.17 | 100 | Phosphopentomutase, putative | 44429.2/5.33 | 20 | 341 | deoB/NT01EI_0564 |
|
| |||||||||
| 238918700 | 16 | 147 | 2.46 | 100 | Pyruvate dehydrogenase; acetyl-transferring, homodimeric type, putative | 99427.8/5.55 | 20 | 169 | NT01EI_0758 |
| 238918702 | 17 | 819/833 | 2.51 | 100 | Dihydrolipoyl dehydrogenase, putative | 50803.5/5.64 | 19 | 397 | NT01EI_0760 |
| 238919229 | 18 | 1144 | 4.49 | 100 | Udp-glucose 6-dehydrogenase | 43359.6/6.09 | 11 | 113 | NT01EI_1312 |
| 238918818 | 19 | 1288 | 3.08 | 100 | 1,3-propanediol dehydrogenase | 40188.1/5.45 | 15 | 467 | NT01EI_0882 |
| 238920005 | 20 | 2096 | -3.67 | 100 | Superoxide dismutase | 21120.4/5.26 | 5 | 364 | Sod_Fe/NT01EI_2109 |
|
| |||||||||
| 238921741 | 21 | 713 | 3.68 | 100 | ATP synthase subunit alpha/ AltName: F-ATPase subunit alpha | 55190.7/5.59 | 24 | 491 | atpA/NT01EI_3910 |
| 238920582 | 22 | 1171 | 2.1 | 100 | Acetate kinase, putative | 43096/5.9 | 17 | 517 | NT01EI_2694 |
| 238920730 | 23 | 1243 | 2.45 | 100 | Galactokinase, putative | 41138.9/5.83 | 18 | 411 | NT01EI_2843 |
|
| |||||||||
| 238921444 | 24 | 1082 | 2.28 | 100 | Elongation factor Tu | 43262.2/5.15 | 19 | 672 | NT01EI_3596 |
| 238918136 | 25 | 1095 | 3.71 | 100 | Translation elongation factor Tu, putative | 43262.2/5.15 | 23 | 866 | NT01EI_0167 |
| 238919786 | 26 | 1289 | 2.02 | 100 | Phenylalanyl-tRNA synthetase, alpha subunit, putative | 36890.7/5.9 | 25 | 581 | pheS/NT01EI_1890 |
| 238921441 | 27 | 2020 | 2.47 | 100 | 50S ribosomal protein L4 | 22068.8/9.72 | 7 | 198 | rplD/NT01EI_3593 |
| 238918424 | 28 | 102 | 6.95 | 100 | Translation initiation factor IF-2, putative | 98155.7/5.72 | 21 | 158 | infB/NT01EI_0467 |
| 238921430 | 29 | 2095 | -2.95 | 100 | RecName: Full = 50S ribosomal protein L5 | 20333.7/9.59 | 12 | 248 | rplE/NT01EI_3582 |
| 238917996 | 30 | 428/406 | -2.61/-4.78 | 100 | Glycyl-tRNA synthetase, beta subunit, putative | 75997.9/5.35 | 37 | 633 | glyS/NT01EI_0014 |
|
| |||||||||
| 238918184 | 31 | 1099 | 8.77 | 100 | Maltoporin | 46962.3/5.18 | 18 | 576 | lamB/NT01EI_0220 |
| 238918180 | 32 | 1314/1303 | 8.73 | 100 | Bacterial extracellular solute-binding protein, putative | 43474.5/6.48 | 24 | 494 | malE/NT01EI_0216 |
| 238918185 | 33 | 1570 | 4.86 | 100 | Maltose operon periplasmic protein | 31714.5/8.77 | 8 | 121 | malM/NT01EI_0221 |
| 238919805 | 34 | 551/541 | 17.95 | 100 | TonB-dependent heme/hemoglobin receptor family protein | 72860.4/6.13 | 33 | 457 | chuA/NT01EI_1909 |
| 238920966 | 35 | 1442 | 2.74 | 100 | ABC transporter, substrate binding protein | 37823.6/7.79 | 14 | 352 | NT01EI_3096 |
| 238919569 | 36 | 675 | -2.82 | 100 | Periplasmic oligopeptide-binding protein | 61472.2/6.82 | 12 | 136 | oppA/NT01EI_1668 |
|
| |||||||||
| 238920751 | 37 | 540 | 6.3 | 100 | Succinate dehydrogenase, flavoprotein subunit, putative | 64419.1/5.94 | 29 | 500 | sdhA/NT01EI_2870 |
| 238918339 | 38 | 795 | 3.25 | 100 | Aspartate ammonia-lyase, putative | 52454.8/5.33 | 17 | 436 | aspA/NT01EI_0377 |
|
| |||||||||
| 238921325 | 39 | 1353 | 2.1 | 100 | Glycerophosphoryl diester phosphodiesterase | 40878.5/6.01 | 17 | 303 | NT01EI_3469 |
| 238920583 | 40 | 188 | 4.22 | 100 | Phosphate acetyltransferase | 76925/5.46 | 21 | 221 | NT01EI_2695 |
| 238918772 | 41 | 1364 | 2.48 | 100 | Methionine aminopeptidase, type I, putative | 29710.1/5.63 | 12 | 298 | NT01EI_0835 |
| 238918900 | 42 | 1935 | 2 | 100 | Hypothetical protein NT01EI_0965 | 23510.7/6.92 | 14 | 359 | esrB/NT01EI_0965 |
| 238919128 | 43 | 2094 | -3.03 | 100 | Glycine cleavage system transcriptional repressor | 20825.4/5.03 | 7 | 82 | gcvR/NT01EI_1199 |
| 238921227 | 44 | 407 | -2.51 | 100 | Transketolase 1 (TK 1) | 72356/5.66 | 19 | 197 | tktA/NT01EI_3370 |
| 238921714 | 45 | 2099 | -3.35 | 99.99 | Thiol:disulfide interchange protein DsbA | 22948.7/5.79 | 5 | 79 | dsbA/NT01EI_3876 |
| 238921092 | 46 | 2148 | -2.74 | 100 | Hypothetical protein NT01EI_3227 | 18959.4/5.6 | 9 | 330 | luxS/NT01EI_3227 |
| 238919302 | 47 | 1968 | -4.79 | 100 | Outer membrane protein A | 38075.3/8.79 | 12 | 200 | ompA/NT01EI_1392 |
| 238919598 | 48 | 1868 | -2.68 | 100 | Hypothetical protein NT01EI_1697 | 27900.5/8.98 | 15 | 307 | NT01EI_1697 |
| 238920203 | 49 | 1596/1598 | -2.78/-2.34 | 100 | Hypothetical protein NT01EI_2312 | 31984.4/6.92 | 21 | 656 | NT01EI_2312 |
| 238920625 | 50 | 2159 | -2.33 | 100 | Hypothetical protein NT01EI_2737 | 19363.8/5.29 | 9 | 123 | eip20/NT01EI_2737 |
Fig 2Biological process gene ontology (GO) Slim of differentially abundant proteins of Edwardsiella ictaluri grown in in vitro iron restriction condition.
All biological process GO annotations of up- and down-regulated proteins were summarized to more generalized GO categories based on ancestor chart for GO terms at QuickGO. Number of proteins involved in various generalized GO biological process categories was represented.
Fig 3Molecular function gene ontology (GO) Slim of differentially abundant proteins of Edwardsiella ictaluri grown in in vitro iron-restriction condition.
All molecular functional GO annotations of up- and down-regulated proteins were summarized to more generalized GO categories based on ancestor chart for GO terms at QuickGO. Number of proteins involved in various generalized GO molecular functional categories was shown.
Fig 4Subcellular locations of Edwardsiella ictaluri proteins differentially regulated due to in vitro iron-restriction were predicted using PSORTb.
Number of differentially abundant proteins, identified in this study, predicted to be located in various subcellular locations was shown. Unknown category includes proteins with multiple subcellular localizations or unknown location.
List of pathways significantly represented by differentially regulated Edwardsiella ictaluri proteins in response to in vitro iron-restriction.
| Name | No. of proteins | p-value | Classification |
|---|---|---|---|
| Glycolysis / Gluconeogenesis | 8 | 1.29E-06 | Carbohydrate Metabolism |
| Pyruvate metabolism | 8 | 2.31E-06 | Carbohydrate Metabolism |
| Pentose phosphate pathway | 5 | 2.66E-04 | Carbohydrate Metabolism |
| Citrate cycle (TCA cycle) | 3 | 1.06E-02 | Carbohydrate Metabolism |
| Butanoate metabolism | 4 | 1.51E-02 | Carbohydrate Metabolism |
| Propanoate metabolism | 3 | 4.01E-02 | Carbohydrate Metabolism |
| Glycerolipid metabolism | 3 | 1.96E-02 | Lipid Metabolism |
| Selenoamino acid metabolism | 6 | 5.49E-05 | Metabolism of Other Amino Acids |
| Taurine and hypotaurine metabolism | 2 | 4.57E-02 | Metabolism of Other Amino Acids |
| Purine metabolism | 5 | 2.14E-02 | Nucleotide Metabolism |
Fig 5Protein interaction network of differentially regulated Edwardsiella ictaluri proteins due to in vitro iron-restriction.
Entities shown in red and blue were up- and down-regulated protein, respectively, due to in vitro iron-restriction. Intensity of color indicates the fold-difference in protein abundance. Each entity represents protein, arrow indicates binding, > indicates post-translational regulation, and → indicates abundance regulation.